SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Chia-Hung Chiang, Chia-Jen Liu, Ping-Jen Chen, Chin-Chou Huang, Chien-Yi Hsu, Zu-Yin Chen, Wan-Leong Chan, Po-Hsun Huang, Tzeng-Ji Chen, Chia-Min Chung, Shing-Jong Lin, Jaw-Wen Chen, Hsin-Bang Leu, Hip fracture and risk of acute myocardial infarction: A nationwide study, Journal of Bone and Mineral Research, 2013, 28, 2
  2. 2
    D.L. Alekel, C.M. Weaver, M.J.J. Ronis, W.E. Ward, Bioactive Food as Dietary Interventions for the Aging Population, 2013,

    CrossRef

  3. 3
    Y. Guo, J.-T. Wang, H. Liu, M. Li, T.-L. Yang, X.-W. Zhang, Y.-Z. Liu, Q. Tian, H.-W. Deng, Are bone mineral density loci associated with hip osteoporotic fractures? A validation study on previously reported genome-wide association loci in a Chinese population, Genetics and Molecular Research, 2012, 11, 1, 202

    CrossRef

  4. 4
    Devinder K.A. Singh, Bala S. Rajaratnam, Vijayakumar Palaniswamy, Hannah Pearson, Vimal P. Raman, Pei Sien Bong, Participating in a virtual reality balance exercise program can reduce risk and fear of falls, Maturitas, 2012, 73, 3, 239

    CrossRef

  5. 5
    Gulay Karaguzel, Michael F. Holick, Diagnosis and treatment of osteopenia, Reviews in Endocrine and Metabolic Disorders, 2010, 11, 4, 237

    CrossRef

  6. 6
    M.V. Groba Marco, S. García Santana, A. Mirallave Pescador, E. González Rodríguez, E. González Padilla, M. Sosa Henríquez, Enfermedades metabólicas óseas. Introducción. Remodelado óseo y pérdida ósea. Osteoporosis: concepto, epidemiología, morbilidad y mortalidad. Repercusiones económicas de la osteoporosis. Enfermedad infradiagnosticada, Medicine - Programa de Formación Médica Continuada Acreditado, 2010, 10, 60, 4109

    CrossRef

  7. 7
    Michael Maricic, Intravenous Zoledronic Acid: What Are the Indications for Male Osteoporosis?, Current Osteoporosis Reports, 2010, 8, 1, 4

    CrossRef

  8. 8
    G. Breart, C. Cooper, O. Meyer, C. Speirs, N. Deltour, J. Y. Reginster, Osteoporosis and venous thromboembolism: a retrospective cohort study in the UK General Practice Research Database, Osteoporosis International, 2010, 21, 7, 1181

    CrossRef

  9. 9
    Yuan Chen, Hui Shen, Fang Yang, Peng-Yuan Liu, Nelson Tang, Robert R. Recker, Hong-Wen Deng, Choice of study phenotype in osteoporosis genetic research, Journal of Bone and Mineral Metabolism, 2009, 27, 2, 121

    CrossRef

  10. 10
    D. Cecilia, E. Jódar, C. Fernández, C. Resines, F. Hawkins, Effect of alendronate in elderly patients after low trauma hip fracture repair, Osteoporosis International, 2009, 20, 6, 903

    CrossRef

  11. 11
    Elena Segal, Valentina Raichlin, Sophia Rimbrot, Chaim Zinman, Batia Raz, Sophia Ish-Shalom, Hip fractures in the elderly in Israel—Possible impact of preventable conditions, Archives of Gerontology and Geriatrics, 2009, 48, 2, 182

    CrossRef

  12. 12
    Han Bok Kwak, Jong Yun Kim, Kwang Jin Kim, Min-Kye Choi, Jeong-Joong Kim, Kwang Mee Kim, Yong-Il Shin, Myeung Su Lee, Hun Soo Kim, Jeung Woo Kim, Chul Hong Chun, Hae Joong Cho, Gi Youn Hong, Seon Kwan Juhng, Kwon Ha Yoon, Byoung Hyun Park, Ji Myung Bae, Joung-Kyue Han, Jaemin Oh, Risedronate Directly Inhibits Osteoclast Differentiation and Inflammatory Bone Loss, Biological & Pharmaceutical Bulletin, 2009, 32, 7, 1193

    CrossRef

  13. 13
    C.M. Arnold, A.J. Busch, C.L. Schachter, E.L. Harrison, W.P. Olszynski, A Randomized Clinical Trial of Aquatic versus Land Exercise to Improve Balance, Function, and Quality of Life in Older Women with Osteoporosis, Physiotherapy Canada, 2008, 60, 4, 296

    CrossRef

  14. 14
    Jidong Lian, Marc Mackenzie, Kurian Joseph, Nadeem Pervez, George Dundas, Raul Urtasun, Robert Pearcey, Assessment of Extended-Field Radiotherapy for Stage IIIC Endometrial Cancer Using Three-Dimensional Conformal Radiotherapy, Intensity-Modulated Radiotherapy, and Helical Tomotherapy, International Journal of Radiation Oncology*Biology*Physics, 2008, 70, 3, 935

    CrossRef

  15. 15
    John-Arne Skolbekken, Wenche Østerlie, Siri Forsmo, Brittle bones, pain and fractures – Lay constructions of osteoporosis among Norwegian women attending the Nord-Trøndelag Health Study (HUNT), Social Science & Medicine, 2008, 66, 12, 2562

    CrossRef

  16. 16
    I. Serralta-Davia, J. Girbés-Borrás, Motivos de consulta en rehabilitación en pacientes con factores de riesgo clínico de osteoporosis, Rehabilitación, 2008, 42, 2, 73

    CrossRef

  17. 17
    Roland D Chapurlat, Single annual injectable treatment for postmenopausal osteoporosis, Expert Opinion on Drug Delivery, 2008, 5, 5, 583

    CrossRef

  18. 18
    Silvano Adami, Bisphosphonate antifracture efficacy, Bone, 2007, 41, 5, S8

    CrossRef

  19. 19
    M. A. Périer, E. Gineyts, F. Munoz, E. Sornay-Rendu, P. D. Delmas, Homocysteine and fracture risk in postmenopausal women: the OFELY study, Osteoporosis International, 2007, 18, 10, 1329

    CrossRef

  20. 20
    David A. Hanley, Qiaoyi Zhang, Marie-Claude Meilleur, Panagiotis Mavros, Shuvayu S. Sen, Prescriptions for vitamin Damong patients taking antiresorptive agents in Canada, Current Medical Research and Opinion, 2007, 23, 6, 1473

    CrossRef

  21. 21
    M. Stauber, R. Müller, Age-related changes in trabecular bone microstructures: global and local morphometry, Osteoporosis International, 2006, 17, 4, 616

    CrossRef

  22. 22
    Robert L. Ohsfeldt, Natalie N. Borisov, Richard L. Sheer, Fragility fracture-related direct medical costs in the first year following a nonvertebral fracture in a managed care setting, Osteoporosis International, 2006, 17, 2, 252

    CrossRef

  23. 23
    Gérard Chalès, Pascal Guggenbuhl, Os et foie, EMC - Hépatologie, 2006, 1, 1, 1

    CrossRef

  24. 24
    Jean-Yves Reginster, Véronique Rabenda, Patient preference in the management of postmenopausal osteoporosis with bisphosphonates, Clinical Interventions in Aging, 2006, 1, 4, 415

    CrossRef

  25. 25
    Alireza Moayyeri, Akbar Soltani, Hossein Bahrami, Mohsen Sadatsafavi, Mehdi Jalili, Bagher Larijani, Preferred skeletal site for osteoporosis screening in high-risk populations, Public Health, 2006, 120, 9, 863

    CrossRef

  26. 26
    Cosimo Roberto Russo, Fulvio Lauretani, Ego Seeman, Benedetta Bartali, Stefania Bandinelli, Angelo Di Iorio, Jack Guralnik, Luigi Ferrucci, Structural adaptations to bone loss in aging men and women, Bone, 2006, 38, 1, 112

    CrossRef

  27. 27
    Solomon Epstein, Update of current therapeutic options for the treatment of postmenopausal osteoporosis, Clinical Therapeutics, 2006, 28, 2, 151

    CrossRef

  28. 28
    D Lee Alekel, Handbook of Nutraceuticals and Functional Foods, Second Edition, 2006,

    CrossRef

  29. 29
    Andrea Z. LaCroix, Diana S.M. Buist, Susan K. Brenneman, Thomas A. Abbott, Evaluation of Three Population-Based Strategies for Fracture Prevention, Medical Care, 2005, 43, 3, 293

    CrossRef

  30. 30
    Ghada El-Hajj Fuleihan, Rafic Baddoura, Hassane Awada, Jad Okais, Paul Rizk, Michael McClung, Lebanese Guidelines for Osteoporosis Assessment and Treatment, Journal of Clinical Densitometry, 2005, 8, 2, 148

    CrossRef

  31. 31
    Ilksen Gurkan, Alfred F. Faust, Simon C. Mears, James F. Wenz, Epidemiology and financial burden of hip fractures, Current Opinion in Orthopaedics, 2004, 15, 1, 8

    CrossRef

  32. 32
    Anne C. Looker, Principles of Gender-Specific Medicine, 2004,

    CrossRef

  33. 33
    K D Cashman, F. Branca, Functional foods, ageing and degenerative disease, 2004,

    CrossRef

  34. 34
    Theodore T. Suh, Kenneth W. Lyles, Osteoporosis considerations in the frail elderly, Current Opinion in Rheumatology, 2003, 15, 4, 481

    CrossRef

  35. 35
    Bo Abrahamsen, Charlotte Landbo Tofteng, Olaf Bärenholdt, Peter Vestergaard, Lis Saalbach Stilgren, Henning Beck-Nielsen, Stig Pors Nielsen, Ole Helmer Sϕrensen, Leif Mosekilde, Standardization of BMD T-Scores in the First Five Years After the Menopause, Journal of Clinical Densitometry, 2003, 6, 2, 87

    CrossRef

  36. 36
    Daniel A. Oakes, Kent R. Jackson, Mark R. Davies, Kevin M. Ehrhart, Gary L. Zohman, Kenneth J. Koval, Jay R. Lieberman, The Impact of the Garden Classification on Proposed Operative Treatment, Clinical Orthopaedics and Related Research, 2003, 409, 232

    CrossRef

  37. 37
    L.Joseph Melton, Robert P. Heaney, Too much medicine? or too little?, Bone, 2003, 32, 4, 327

    CrossRef

  38. 38
    William J. Tremaine, Sundeep Khosla, Bisphosphonates and the Upper Gastrointestinal Tract: Skeletal Gain Without Visceral Pain?, Mayo Clinic Proceedings, 2002, 77, 10, 1029

    CrossRef

  39. 39
    Steven R Cummings, L Joseph Melton, Epidemiology and outcomes of osteoporotic fractures, The Lancet, 2002, 359, 9319, 1761

    CrossRef

  40. 40
    K.M. Jordan, C. Cooper, Epidemiology of osteoporosis, Best Practice & Research Clinical Rheumatology, 2002, 16, 5, 795

    CrossRef

  41. 41
    L.J. Melton, S.J. Achenbach, W.M. O’fallon, S. Khosla, Secondary osteoporosis and the risk of distal forearm fractures in men and women, Bone, 2002, 31, 1, 119

    CrossRef

  42. 42
    Brian R. MacDonald, Maxine Gowen, Emerging therapies in osteoporosis, Best Practice & Research Clinical Rheumatology, 2001, 15, 3, 483

    CrossRef

  43. 43
    SHERRY SHERMAN, Preventing and Treating Osteoporosis, Annals of the New York Academy of Sciences, 2001, 949, 1
  44. 44
    Alison Avenell, William J Gillespie, Lesley D Gillespie, Dianne O'Connell, Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis, The Cochrane Library,
  45. 45
    Alison Avenell, William J Gillespie, Lesley D Gillespie, Dianne O'Connell, Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis, The Cochrane Library,